ICECURE MEDICAL LTD (ICCM) Stock Fundamental Analysis

NASDAQ:ICCM • IL0011224156

0.572 USD
+0 (+0.14%)
Last: Feb 23, 2026, 04:30 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

ICCM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While ICCM seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ICCM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ICCM has reported negative net income.
  • ICCM had a negative operating cash flow in the past year.
  • In the past 5 years ICCM always reported negative net income.
  • In the past 5 years ICCM always reported negative operating cash flow.
ICCM Yearly Net Income VS EBIT VS OCF VS FCFICCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • ICCM's Return On Assets of -101.41% is on the low side compared to the rest of the industry. ICCM is outperformed by 78.92% of its industry peers.
  • ICCM's Return On Equity of -164.30% is on the low side compared to the rest of the industry. ICCM is outperformed by 69.73% of its industry peers.
Industry RankSector Rank
ROA -101.41%
ROE -164.3%
ROIC N/A
ROA(3y)-89.11%
ROA(5y)-66.89%
ROE(3y)-136.41%
ROE(5y)-102.39%
ROIC(3y)N/A
ROIC(5y)N/A
ICCM Yearly ROA, ROE, ROICICCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800 1K

1.3 Margins

  • With a Gross Margin value of 35.06%, ICCM is not doing good in the industry: 72.97% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ICCM has grown nicely.
  • ICCM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.03%
GM growth 5Y4.86%
ICCM Yearly Profit, Operating, Gross MarginsICCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ICCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ICCM has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ICCM has more shares outstanding
  • ICCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ICCM Yearly Shares OutstandingICCM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICCM Yearly Total Debt VS Total AssetsICCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -9.24, we must say that ICCM is in the distress zone and has some risk of bankruptcy.
  • ICCM's Altman-Z score of -9.24 is on the low side compared to the rest of the industry. ICCM is outperformed by 77.30% of its industry peers.
  • ICCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.24
ROIC/WACCN/A
WACC8.58%
ICCM Yearly LT Debt VS Equity VS FCFICCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • ICCM has a Current Ratio of 2.38. This indicates that ICCM is financially healthy and has no problem in meeting its short term obligations.
  • ICCM has a Current ratio of 2.38. This is comparable to the rest of the industry: ICCM outperforms 44.86% of its industry peers.
  • A Quick Ratio of 1.90 indicates that ICCM should not have too much problems paying its short term obligations.
  • ICCM has a Quick ratio (1.90) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 1.9
ICCM Yearly Current Assets VS Current LiabilitesICCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 8.77% over the past year.
  • The Revenue for ICCM has decreased by -18.96% in the past year. This is quite bad
  • The Revenue has been growing by 15.37% on average over the past years. This is quite good.
EPS 1Y (TTM)8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-18.96%
Revenue growth 3Y-7.36%
Revenue growth 5Y15.37%
Sales Q2Q%28.4%

3.2 Future

  • ICCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.59% yearly.
  • The Revenue is expected to grow by 90.27% on average over the next years. This is a very strong growth
EPS Next Y26.9%
EPS Next 2Y22.76%
EPS Next 3Y20.78%
EPS Next 5Y23.59%
Revenue Next Year11.03%
Revenue Next 2Y20.78%
Revenue Next 3Y104.63%
Revenue Next 5Y90.27%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICCM Yearly Revenue VS EstimatesICCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M
ICCM Yearly EPS VS EstimatesICCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 -0.2 0.4 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ICCM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICCM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICCM Price Earnings VS Forward Price EarningsICCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICCM Per share dataICCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

  • ICCM's earnings are expected to grow with 20.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.76%
EPS Next 3Y20.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ICCM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICECURE MEDICAL LTD

NASDAQ:ICCM (2/23/2026, 4:30:02 PM)

0.572

+0 (+0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-19
Earnings (Next)03-03
Inst Owners0.43%
Inst Owner Change56.32%
Ins Owners40.42%
Ins Owner ChangeN/A
Market Cap39.45M
Revenue(TTM)2.98M
Net Income(TTM)-15.29M
Analysts82.5
Price Target3.19 (457.69%)
Short Float %1.33%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.07%
Min EPS beat(2)-17.65%
Max EPS beat(2)9.5%
EPS beat(4)2
Avg EPS beat(4)3.44%
Min EPS beat(4)-17.65%
Max EPS beat(4)26.47%
EPS beat(8)5
Avg EPS beat(8)4.51%
EPS beat(12)8
Avg EPS beat(12)5.2%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-22.31%
Max Revenue beat(2)16.71%
Revenue beat(4)1
Avg Revenue beat(4)-7.62%
Min Revenue beat(4)-22.31%
Max Revenue beat(4)16.71%
Revenue beat(8)3
Avg Revenue beat(8)-5.39%
Revenue beat(12)3
Avg Revenue beat(12)-12.47%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)16.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.26
P/FCF N/A
P/OCF N/A
P/B 4.24
P/tB 4.24
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.04
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -101.41%
ROE -164.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.06%
FCFM N/A
ROA(3y)-89.11%
ROA(5y)-66.89%
ROE(3y)-136.41%
ROE(5y)-102.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.03%
GM growth 5Y4.86%
F-Score2
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.76%
Cap/Sales 1.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 1.9
Altman-Z -9.24
F-Score2
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)175.33%
Cap/Depr(5y)260.07%
Cap/Sales(3y)15.28%
Cap/Sales(5y)12.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y26.9%
EPS Next 2Y22.76%
EPS Next 3Y20.78%
EPS Next 5Y23.59%
Revenue 1Y (TTM)-18.96%
Revenue growth 3Y-7.36%
Revenue growth 5Y15.37%
Sales Q2Q%28.4%
Revenue Next Year11.03%
Revenue Next 2Y20.78%
Revenue Next 3Y104.63%
Revenue Next 5Y90.27%
EBIT growth 1Y-5.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.83%
OCF growth 3YN/A
OCF growth 5YN/A

ICECURE MEDICAL LTD / ICCM FAQ

What is the fundamental rating for ICCM stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICCM.


What is the valuation status of ICECURE MEDICAL LTD (ICCM) stock?

ChartMill assigns a valuation rating of 1 / 10 to ICECURE MEDICAL LTD (ICCM). This can be considered as Overvalued.


How profitable is ICECURE MEDICAL LTD (ICCM) stock?

ICECURE MEDICAL LTD (ICCM) has a profitability rating of 1 / 10.


What is the financial health of ICECURE MEDICAL LTD (ICCM) stock?

The financial health rating of ICECURE MEDICAL LTD (ICCM) is 5 / 10.


What is the earnings growth outlook for ICECURE MEDICAL LTD?

The Earnings per Share (EPS) of ICECURE MEDICAL LTD (ICCM) is expected to grow by 26.9% in the next year.